Macula Risk PGx provides a powerful tool for the primary eye care provider and retina specialist to more precisely manage their patients with macular degeneration. This in turn informs better management practices as well as a more efficient utilization of limited resources.
Macula Risk® PGx is a combined prognostic and pharmacogenetic DNA test designed to determine a patient’s risk of progression to advanced Age-related Macular Degeneration (AMD) and aid in the selection of appropriate eye vitamin formulations for AMD based on his or her individual genetic risk profile.
